WAM
HRMY icon

Watershed Asset Management’s Harmony Biosciences HRMY Stock Holding History

Watershed Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,285
Closed -$422K – 134
2025
Q4 		$422K Buy
+11,285
New +$371K 0.39% 94
2023
Q4 		– Sell
-6,929
Closed -$227K – 131
2023
Q3 		$227K Buy
6,929
+246
+4% +$8.54K 0.27% 115
2023
Q2 		$235K Buy
+6,683
New +$231K 0.29% 100

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Watershed Asset Management's HRMY Position: Q1 2026 in Review

Watershed Asset Management sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 11,285 shares — an estimated $422K sold.

Watershed Asset Management first reported a position in HRMY in Q2 2023 and held it in 3 quarters. The position peaked at $422K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Watershed Asset Management reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Watershed Asset Management sold 11,285 Harmony Biosciences shares in Q1 2026, an estimated $422K.
  • Watershed Asset Management first reported a position in Harmony Biosciences in Q2 2023 and held it in 3 quarters.
  • Watershed Asset Management's Harmony Biosciences position peaked at $422K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Watershed Asset Management's 13F filing for Q1 2026, filed 6 May 2026.